Proteomic analysis of liver tissue samples has identified upregulated MFAP4 in HBV/HCV-associated hepatic fibrosis [33], and several reports have suggested that serum MFAP4 levels can be used as a non-invasive tool for screening liver fibrosis [34,35]. The gene discussed is MFAP4; the disease is Hepatic fibrosis.